No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE Study.

Cancers (Basel) · 2025 · PMC12691049 · PMID 41375027

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In a multivariable analysis of predictors for renal decline during treatment (eGFR <50 mL/min/1.73 m 2 ), the strongest independent predictor was a baseline eGFR of ≤60 mL/min/1.73 m 2 (OR 3.72), while baseline hypertension showed a trend toward increased risk (OR 2.70).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.